We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Flow Cytometer System

By Biotechdaily staff writers
Posted on 25 May 2004
A new flow cytometer system is designed to support a full range of research-only applications in immunology, cell biology, and drug discovery.

The cytometer has high-sensitivity optics, extremely low sample-to-sample carryover, and rapid processing rates of up to 10,000 events per second. More...
The total benefit consists of high fluorescence sensitivity to resolve dim events, cleaner data due to minimal sample contamination, and high processing speed. From BD Biosciences, a segment of Becton, Dickinson and Company (San Jose, CA, USA), the system is called the BD FacsCanto. The company says it overcomes obstacles known in rare event analysis and in functional studies for low detection ranges. The system is for research use only, not for use in diagnostic or therapeutic procedures.

"The BD FacsCanto system was designed using 30 years of experience and expertise in flow cytometry from BD Biosciences,” said Jeanne Brosnan, vice president, marketing, at BD Biosciences. "The BD FacsCanto flow cytometry system is yet another technological innovation from a world leader in cell sorting and analysis.”




Related Links:
BD Biosciences

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Pipette Calibration System
Artel PCS®
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.